195 related articles for article (PubMed ID: 23697711)
21. UDP-galactopyranose mutase has a novel structure and mechanism.
Sanders DA; Staines AG; McMahon SA; McNeil MR; Whitfield C; Naismith JH
Nat Struct Biol; 2001 Oct; 8(10):858-63. PubMed ID: 11573090
[TBL] [Abstract][Full Text] [Related]
22. Probing UDP-galactopyranose mutase binding pocket: a dramatic effect on substitution of the 6-position of UDP-galactofuranose.
Eppe G; Peltier P; Daniellou R; Nugier-Chauvin C; Ferrières V; Vincent SP
Bioorg Med Chem Lett; 2009 Feb; 19(3):814-6. PubMed ID: 19119008
[TBL] [Abstract][Full Text] [Related]
23. Eukaryotic UDP-galactopyranose mutase (GLF gene) in microbial and metazoal pathogens.
Beverley SM; Owens KL; Showalter M; Griffith CL; Doering TL; Jones VC; McNeil MR
Eukaryot Cell; 2005 Jun; 4(6):1147-54. PubMed ID: 15947206
[TBL] [Abstract][Full Text] [Related]
24. In Crystallo Capture of a Covalent Intermediate in the UDP-Galactopyranose Mutase Reaction.
Mehra-Chaudhary R; Dai Y; Sobrado P; Tanner JJ
Biochemistry; 2016 Feb; 55(6):833-6. PubMed ID: 26836146
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of nonionic substrate mimics of UDP-Galp as candidate inhibitors of UDP galactopyranose mutase (UGM).
Kuppala R; Borrelli S; Slowski K; Sanders DA; Ravindranathan Kartha KP; Pinto BM
Bioorg Med Chem Lett; 2015 May; 25(9):1995-7. PubMed ID: 25819094
[TBL] [Abstract][Full Text] [Related]
26. Exploring the mechanism of binding of UDP-galactopyranose to UDP-galactopyranose mutase by STD-NMR spectroscopy and molecular modeling.
Yuan Y; Wen X; Sanders DA; Pinto BM
Biochemistry; 2005 Nov; 44(43):14080-9. PubMed ID: 16245924
[TBL] [Abstract][Full Text] [Related]
27. Virtual Screening for UDP-Galactopyranose Mutase Ligands Identifies a New Class of Antimycobacterial Agents.
Kincaid VA; London N; Wangkanont K; Wesener DA; Marcus SA; Héroux A; Nedyalkova L; Talaat AM; Forest KT; Shoichet BK; Kiessling LL
ACS Chem Biol; 2015 Oct; 10(10):2209-18. PubMed ID: 26214585
[TBL] [Abstract][Full Text] [Related]
28. 1,4-Anhydrogalactopyranose is not an intermediate of the mutase catalyzed UDP-galactopyranose/furanose interconversion.
Caravano A; Sinaÿ P; Vincent SP
Bioorg Med Chem Lett; 2006 Mar; 16(5):1123-5. PubMed ID: 16377186
[TBL] [Abstract][Full Text] [Related]
29. Identification of Novel Inhibitors of UDP-Galactopyranose Mutase by Structure-Based Virtual Screening.
Karunan Partha S; Sadeghi-Khomami A; Cren S; Robinson RI; Woodward S; Slowski K; Berast L; Zheng B; Thomas NR; Sanders DA
Mol Inform; 2011 Oct; 30(10):873-83. PubMed ID: 27468107
[TBL] [Abstract][Full Text] [Related]
30. Targeting UDP-galactopyranose mutases from eukaryotic human pathogens.
Kizjakina K; Tanner JJ; Sobrado P
Curr Pharm Des; 2013; 19(14):2561-73. PubMed ID: 23116395
[TBL] [Abstract][Full Text] [Related]
31. Structure, mechanism, and dynamics of UDP-galactopyranose mutase.
Tanner JJ; Boechi L; Andrew McCammon J; Sobrado P
Arch Biochem Biophys; 2014 Feb; 544():128-41. PubMed ID: 24096172
[TBL] [Abstract][Full Text] [Related]
32. Identification of eukaryotic UDP-galactopyranose mutase inhibitors using the ThermoFAD assay.
Martín Del Campo JS; Eckshtain-Levi M; Sobrado P
Biochem Biophys Res Commun; 2017 Nov; 493(1):58-63. PubMed ID: 28919416
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and inhibition properties of conformational probes for the mutase-catalyzed UDP-galactopyranose/furanose interconversion.
Caravano A; Mengin-Lecreulx D; Brondello JM; Vincent SP; Sinaÿ P
Chemistry; 2003 Dec; 9(23):5888-98. PubMed ID: 14673861
[TBL] [Abstract][Full Text] [Related]
34. Mechanistic investigation of UDP-galactopyranose mutase from Escherichia coli using 2- and 3-fluorinated UDP-galactofuranose as probes.
Zhang Q; Liu H
J Am Chem Soc; 2001 Jul; 123(28):6756-66. PubMed ID: 11448178
[TBL] [Abstract][Full Text] [Related]
35. Structural basis of ligand binding to UDP-galactopyranose mutase from Mycobacterium tuberculosis using substrate and tetrafluorinated substrate analogues.
van Straaten KE; Kuttiyatveetil JR; Sevrain CM; Villaume SA; Jiménez-Barbero J; Linclau B; Vincent SP; Sanders DA
J Am Chem Soc; 2015 Jan; 137(3):1230-44. PubMed ID: 25562380
[TBL] [Abstract][Full Text] [Related]
36. UDP-galactopyranose mutases from Leishmania species that cause visceral and cutaneous leishmaniasis.
Fonseca IO; Kizjakina K; Sobrado P
Arch Biochem Biophys; 2013 Oct; 538(2):103-10. PubMed ID: 24012809
[TBL] [Abstract][Full Text] [Related]
37. Crystal structures of Mycobacteria tuberculosis and Klebsiella pneumoniae UDP-galactopyranose mutase in the oxidised state and Klebsiella pneumoniae UDP-galactopyranose mutase in the (active) reduced state.
Beis K; Srikannathasan V; Liu H; Fullerton SW; Bamford VA; Sanders DA; Whitfield C; McNeil MR; Naismith JH
J Mol Biol; 2005 May; 348(4):971-82. PubMed ID: 15843027
[TBL] [Abstract][Full Text] [Related]
38. Inhibitors of UDP-galactopyranose mutase thwart mycobacterial growth.
Dykhuizen EC; May JF; Tongpenyai A; Kiessling LL
J Am Chem Soc; 2008 May; 130(21):6706-7. PubMed ID: 18447352
[TBL] [Abstract][Full Text] [Related]
39. Study of Uridine 5'-Diphosphate (UDP)-Galactopyranose Mutase Using UDP-5-Fluorogalactopyranose as a Probe: Incubation Results and Mechanistic Implications.
Lin GM; Sun HG; Liu HW
Org Lett; 2016 Jul; 18(14):3438-41. PubMed ID: 27384425
[TBL] [Abstract][Full Text] [Related]
40. Enzymatic synthesis of UDP-galactofuranose and an assay for UDP-galactopyranose mutase based on high-performance liquid chromatography.
Lee R; Monsey D; Weston A; Duncan K; Rithner C; McNeil M
Anal Biochem; 1996 Nov; 242(1):1-7. PubMed ID: 8923956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
